236 
Market Cap
Stock Chart
ImpediMed - 30 Day Poll
Recent BLOGS About ImpediMed Add New
Latest Company News
|
Impedimed Limited Announces Pro-rata Accelerated Non-renounceable Entitlement Offer
Reuters Key Development - May 2, 2012 |
|
ImpediMed in pre open ahead of capital raising announcement
Proactive Investors Australia - Apr 30, 2012 ImpediMed (ASX: IPD) has been granted a trading halt by the ASX today as it prepares to release an announcement to the market regarding a proposed capital raising.
|
Website
Videos related to ImpediMed
Company Profile
ImpediMed is a company engaged in the development, manufacture and sale of bio-impedance instruments to direct customers and distributors. The devices are applied to: monitoring of secondary lymphedema, general health assessment and weight management, muscle wasting, drug dosing and monitoring and sports medicine and fitness.
The Company operates in two segments:
1. Medical, which is a supplier of non-invasive medical devices to two under-served markets, such as the assessment of individuals at risk of secondary lymphoedema and the monitoring of body composition and hydration
2. Test & Measurement, which is a supplier of power precision testing and measuring equipment.
Revenue: Approx. $3.2 million as of 30th June 2009 for th year.
Cash: Approx. $6.6 million as of 30th June 2009